Table of contents


From the editors

p169 | doi:10.1038/nri2050

Top

Research Highlights

T helper cells: Self-control by TH1 cells

p171 | doi:10.1038/nri2043

Antigen presentation: Ito cells are liver-resident professional APCs

p172 | doi:10.1038/nri2040

B cells: Caught on camera

p172 | doi:10.1038/nri2051

In the news

Immunity gets a brake

p172 | doi:10.1038/nri2053

In brief

T-cell development | HIV

p173 | doi:10.1038/nri2048

Immune regulation: Vitamin D3 promotes immune function in the skin

p174 | doi:10.1038/nri2047

Autoimmunity: Jump-starting joint disease

p174 | doi:10.1038/nri2052

Signalling: Building bridges with NF-kappaB

p175 | doi:10.1038/nri2042

T-cell development: The SOX switch

p176 | doi:10.1038/nri2044

Autoimmunity: Widening the gender gap

p176 | doi:10.1038/nri2045

Tumour immunotherapy: Shifting the balance

p176 | doi:10.1038/nri2046

In brief

Antiviral immunity | Thymocyte development | Inflammation

p177 | doi:10.1038/nri2049

Top

Reviews

Cooperation of Toll-like receptor signals in innate immune defence

Giorgio Trinchieri and Alan Sher

p179 | doi:10.1038/nri2038

Emerging evidence indicates that the induction of an effective immune response involves the cooperation of multiple Toll-like receptors and other pattern-recognition receptors. Here, the role of this cooperation in host defence against various pathogens and the therapeutic implications are discussed.

PI3Kdelta and PI3Kbold gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?

Christian Rommel, Montserrat Camps and Hong Ji

p191 | doi:10.1038/nri2036

The phosphoinositide 3-kinase (PI3K) isoforms PI3Kdelta and PI3Kgamma generate lipid second messengers that control an array of signalling pathways for numerous immune-cell functions. Recent studies indicate that specific targeting of these PI3K isoforms could be beneficial for treating inflammatory diseases.

MAPK phosphatases — regulating the immune response

Yusen Liu, Edward G. Shepherd and Leif D. Nelin

p202 | doi:10.1038/nri2035

Regulation of the immune response is crucial for avoiding an excessive inflammatory response. Here, recent advances in our understanding of the regulation of mitogen-activated protein kinase (MAPK) phosphatases and their emergence as key regulators of both innate and adaptive immunity are discussed.

Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential

Kenneth Dorshkind and Encarnacion Montecino-Rodriguez

p213 | doi:10.1038/nri2019

B-1 cells are a minor population of B cells that function as effectors of innate immune responses in serous cavities. But where and when do they first emerge in the developing embryo? And do they originate from a distinct progenitor?

Suppression of TH2-type allergic reactions by helminth infection

Padraic G. Fallon and Niamh E. Mangan

p220 | doi:10.1038/nri2039

Individuals infected with parasitic helminths can show a reduction in the development of allergic disorders. Here evidence for a possible role for worms in suppressing allergic responses is examined, with a view to therapeutic strategies for the treatment of allergic diseases.

Top

Perspectives

Opinion

The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery

Arne N. Akbar, Milica Vukmanovic-Stejic, Leonie S. Taams and Derek C. Macallan

p231 | doi:10.1038/nri2037

How can your thymus continue to generate the necessary numbers of CD4+CD25+ regulatory T (TReg) cells once it involutes? Arne Akbar and colleagues propose a model whereby some TReg cells differentiate from rapidly proliferating memory T cells in the periphery.

Opinion

Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response

Daniel M. Davis

p238 | doi:10.1038/nri2020

The intercellular transfer of cell-surface proteins is known to occur between immune cells, but how common is this occurrence, what are its mechanisms and is it important in influencing the interactions of immune cells?

Extra navigation

Subscribe

Subscribe to Nature Reviews Immunology

Open Innovation Challenges

naturejobs

Advertisement